Triamterene recalls
The FDA has published 7 recalls involving Triamterene since 2014. The latest was reported on 3 Jan 2024. Most were for potency & assay. Lannett has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls7since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 3 Jan 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 43%Class III 4 57%
Why triamterene is recalled
Companies
By year
All triamterene recalls, newest first
7 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Triamterene and Hydrochlorothiazide Capsules, USP, 37.5 mg/25 mg recalled | Cardinal Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg) recalled | Lannett | Potency & Assay | Nationwide |
| Drug | CLASS III | Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg) recalled | Lannett | Potency & Assay | Nationwide |
| Drug | CLASS III | Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg recalled | Mylan Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg recalled | Sandoz | Other | Nationwide |
| Drug | CLASS II | Triamterene/ Hydrochlorothiazide, Tablet, 37.5 mg/25 mg recalled | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Triamterene/Hctz, Tablet, 37.5 mg/25 mg recalled by Aidapak Services | Aidapak Services | Labeling Errors | 4 states |
Should you stop taking Triamterene?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.